Long mutant dystrophins and variable phenotypes: evasion of nonsense-mediated decay?

被引:106
作者
Kerr, TP
Sewry, CA
Robb, SA
Roberts, RG
机构
[1] Kings Coll London, Div Med & Mol Genet, Guys Kings & St Thomas Sch Med, Guys Hosp, London SE1 9RT, England
[2] Guys Hosp, Dept Paediat Neurol, London SE1 9RT, England
[3] Univ London Imperial Coll Sci Technol & Med, Sch Med, Dubowitz Neuromusc Ctr, Dept Paediat & Neonatal Med, London W12 0NN, England
[4] Robert Jones & Agnes Hunt Orthopaed Hosp, Dept Histopathol, Oswestry SY10 7AG, Shrops, England
基金
英国医学研究理事会;
关键词
D O I
10.1007/s004390100598
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
More than 98% of Duchenne muscular dystrophy (DMD) mutations result in the premature termination of the dystrophin open reading frame at various points over its 11-kb length. Despite this wide variation in coding potential (0%-98.6% of the full-length protein), the truncating mutations are associated with a surprisingly uniform severity of phenotype. This uniformity is probably attributable to ablation of the message by nonsense-mediated decay (NMD). The rare truncating mutations that occur near the 3' end of the dystrophin gene (beyond exon 70) can however result in extremely variable phenotypes (both intra- and inter-familially). We suggest that all proteins encoded by such mutant genes are capable in principle of rescuing the DMD phenotype but that NMD abrogates the opportunity to effect this rescue. The observed variability may therefore reflect an underlying variation in the efficiency of NMD between individuals. We discuss this hypothesis with particular reference to a well-characterised Becker muscular dystrophy patient with a frameshift mutation. where expression of a truncated dystrophin rescues the muscular but not mental phenotype.
引用
收藏
页码:402 / 407
页数:6
相关论文
共 26 条
[1]  
Babieri AM, 1996, EUR J HUM GENET, V4, P183
[2]   EFFECT OF DYSTROPHIN GENE DELETIONS ON MESSENGER-RNA LEVELS AND PROCESSING IN DUCHENNE AND BECKER MUSCULAR-DYSTROPHIES [J].
CHELLY, J ;
GILGENKRANTZ, H ;
LAMBERT, M ;
HAMARD, G ;
CHAFEY, P ;
RECAN, D ;
KATZ, P ;
DELACHAPELLE, A ;
KOENIG, M ;
GINJAAR, IB ;
FARDEAU, M ;
TOME, F ;
KAHN, A ;
KAPLAN, JC .
CELL, 1990, 63 (06) :1239-1248
[3]   Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain [J].
Crawford, GE ;
Faulkner, JA ;
Crosbie, RH ;
Campbell, KP ;
Froehner, SC ;
Chamberlain, JS .
JOURNAL OF CELL BIOLOGY, 2000, 150 (06) :1399-1409
[4]  
Emery AE, 1993, DUCHENNE MUSCULAR DY
[5]   Nonsense-mediated mRNA decay in health and disease [J].
Frischmeyer, PA ;
Dietz, HC .
HUMAN MOLECULAR GENETICS, 1999, 8 (10) :1893-1900
[6]  
GARDNER RJ, 1995, AM J HUM GENET, V57, P311
[7]   Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family [J].
Ginjaar, IB ;
Kneppers, ALJ ;
von der Meulen, JDM ;
Anderson, LVB ;
Bremmer-Bout, M ;
van Deutekom, JCT ;
Weegenaar, J ;
den Dunnen, JT ;
Bakker, E .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2000, 8 (10) :793-796
[8]   A perfect message: RNA surveillance and nonsense-mediated decay [J].
Hentze, MW ;
Kulozik, AE .
CELL, 1999, 96 (03) :307-310
[9]   Mechanisms of mRNA surveillance in eukaryotes [J].
Hilleren, P ;
Parker, R .
ANNUAL REVIEW OF GENETICS, 1999, 33 :229-260
[10]   Screening for minor changes in the distal part of the human dystrophin gene in Greek DMD/BMD patients [J].
Kekou, K ;
Mavrou, A ;
Florentin, L ;
Youroukos, S ;
Zafiriou, DI ;
Skouteli, HN ;
Metaxotou, C .
EUROPEAN JOURNAL OF HUMAN GENETICS, 1999, 7 (02) :179-187